Japan-based Takeda Pharmaceutical Company, through its Indian subsidiary Takeda Biopharmaceuticals India, and Dr. Reddy’s ...

US health tech company Massive Bio has appointed international business development consultancy Intralink to support its ...

Australia's Monash University has collaboratd with Weill Cornell Medicine, Cornell University’s academic medical institution, ...

HSA Extends Partnerships to Speed Access to Health Innovations Across Key Markets in Africa, Malaysia and Saudi Arabia ...

Japan has approved the LEQEMBI Pen subcutaneous autoinjector for early Alzheimer’s disease, enabling once-weekly administration at home by patients or care partners.

IASO Bio has received FDA IND clearance for IASO208, the first China-originated lentiviral vector-based in vivo CAR-T therapy to reach this regulatory milestone.

Japan’s MHLW has approved Lundbeck’s Vyepti for prevention of migraine attacks in adults, marking the company’s first planned launch as Marketing Authorisation holder in Japan.

When we designed the small animal holding facility in 2012, we were solving a problem most facility planners preferred to defer: what happens when research needs change, but the walls cannot move? At ...

India-based Gujarat Themis Biosyn Limited (GTBL) has announced the completion of the acquisition of 100% equity shareholding in MicroBiopharm Japan (MBJ), through Themis Biosyn Japan Limited, a wholly ...

Pathology laboratories are navigating some of today’s hardest workflow challenges: rising case volumes, increasing test complexity and persistent staffing constraints. Even small inefficiencies in ...

Swiss firm Tenthpin expands footprint in India with AI, IoMT-based Centre for Life Sciences Innovation Hub in Bengaluru ...

To enable faster, easier and more flexible RNA-to-cDNA synthesis, Thermo Fisher Scientific has introduced Invitrogen™ ...